[3P-0427] New combination therapy of HCC by CDK4/6 inhibitor in combination with a kinase inhibitor
Hepatocellular carcinoma (HCC), CDK4, CDK6, RB1
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.